Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PA) Common Equity (2016 - 2025)

Historic Common Equity for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to $29.2 billion.

  • Metlife's Common Equity fell 633.1% to $29.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 billion, marking a year-over-year decrease of 633.1%. This contributed to the annual value of $27.7 billion for FY2024, which is 842.89% down from last year.
  • As of Q3 2025, Metlife's Common Equity stood at $29.2 billion, which was down 633.1% from $27.9 billion recorded in Q2 2025.
  • Metlife's 5-year Common Equity high stood at $69.4 billion for Q2 2021, and its period low was $25.3 billion during Q3 2022.
  • Moreover, its 5-year median value for Common Equity was $30.3 billion (2023), whereas its average is $38.0 billion.
  • In the last 5 years, Metlife's Common Equity tumbled by 6346.62% in 2022 and then skyrocketed by 2034.76% in 2024.
  • Over the past 5 years, Metlife's Common Equity (Quarter) stood at $50.0 billion in 2021, then tumbled by 39.77% to $30.1 billion in 2022, then grew by 0.42% to $30.3 billion in 2023, then fell by 8.43% to $27.7 billion in 2024, then rose by 5.37% to $29.2 billion in 2025.
  • Its last three reported values are $29.2 billion in Q3 2025, $27.9 billion for Q2 2025, and $27.8 billion during Q1 2025.